2. Academic Validation
  3. E3 Ubiquitin Ligase FBXO3 Drives Neuroinflammation to Aggravate Cerebral Ischemia/Reperfusion Injury

E3 Ubiquitin Ligase FBXO3 Drives Neuroinflammation to Aggravate Cerebral Ischemia/Reperfusion Injury

  • Int J Mol Sci. 2022 Nov 7;23(21):13648. doi: 10.3390/ijms232113648.
Yu Gao 1 2,  Xinyu Xiao 3,  Jing Luo 1 2,  Jianwei Wang 3,  Qiling Peng 3,  Jing Zhao 4 5,  Ning Jiang 1 2,  Yong Zhao 1 2
Affiliations

Affiliations

  • 1 Department of Pathology, Chongqing Medical University, Chongqing 400016, China.
  • 2 Molecular Medicine Diagnostic and Testing Center, Chongqing Medical University, Chongqing 400016, China.
  • 3 School of Basic Medical Science, Chongqing Medical University, Chongqing 400016, China.
  • 4 Institute of Neuroscience, Chongqing Medical University, Chongqing 400016, China.
  • 5 Department of Pathophysiology, Chongqing Medical University, Chongqing 400016, China.
PMID: 36362432 DOI: 10.3390/ijms232113648
Abstract

Ischemic stroke, one of the most universal causes of human mortality and morbidity, is pathologically characterized by inflammatory cascade, especially during the progression of ischemia/reperfusion (I/R) injury. F-Box Protein 3 (FBXO3), a substrate-recognition subunit of SKP1-cullin 1-F-box protein (SCF) E3 Ligase complexes, has recently been proven to be severed as an underlying pro-inflammatory factor in pathological processes of diverse diseases. Given these considerations, the current study aims at investigating whether FBXO3 exerts impacts on inflammation in cerebral I/R injury. In this study, first, it was verified that FBXO3 protein expression increased after a middle cerebral artery occlusion/reperfusion (MCAO/R) model in Sprague-Dawley (SD) rats and was specifically expressed in neurons other than microglia or astrocytes. Meanwhile, in mouse hippocampal neuronal cell line HT22 cells, the elevation of FBXO3 protein was observed after oxygen and glucose deprivation/reoxygenation (OGD/R) treatment. It was also found that interference of FBXO3 with siRNA significantly alleviated neuronal damage via inhibiting the inflammatory response in I/R injury both in vivo and in vitro. The FBXO3 inhibitor BC-1215 was used to confirm the pro-inflammatory effect of FBXO3 in the OGD/R model as well. Furthermore, by administration of FBXO3 siRNA and BC-1215, FBXO3 was verified to reduce the protein level of Homeodomain-Interacting Protein Kinase 2 (HIPK2), likely through the ubiquitin-proteasome system (UPS), to aggravate cerebral I/R injury. Collectively, our results underline the detrimental effect FBXO3 has on cerebral I/R injury by accelerating inflammatory response, possibly through ubiquitylating and degrading HIPK2. Despite the specific interaction between FBXO3 and HIPK2 requiring further study, we believe that our data suggest the therapeutic relevance of FBXO3 to ischemic stroke and provide a new perspective on the mechanism of I/R injury.

Keywords

FBXO3; HIPK2; cerebral ischemia/reperfusion injury; inflammation; ischemic stroke; neuronal damage.

Figures
Products